Holen Sie sich die Stockscreener-App
0.70
0.74%
-0.0052
Schlusskurs vom Vortag:
$0.7052
Offen:
$0.716
24-Stunden-Volumen:
17,555
Relative Volume:
0.04
Marktkapitalisierung:
$5.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.28M
KGV:
-0.0503
EPS:
-13.91
Netto-Cashflow:
$-13.75M
1W Leistung:
-0.38%
1M Leistung:
-0.74%
6M Leistung:
-46.15%
1J Leistung:
-85.36%
1-Tages-Spanne:
$0.6902
$0.7227
1-Wochen-Bereich:
$0.6719
$0.7321
52-Wochen-Spanne:
$0.65
$7.50
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Firmenname
Pasithea Therapeutics Corp
Sektor
Branche
Telefon
(702) 514-4174
Adresse
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Vergleichen Sie KTTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.70 | 5.29M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.69 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
604.25 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.66 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
663.30 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
310.83 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pasithea Therapeutics Corp Aktie (KTTA) Neueste Nachrichten
Is Pasithea Therapeutics Corp. Equity Warrant reversing from oversold territory2025 Price Momentum & Weekly High Return Stock Forecasts - Newser
Options Data Show Bullish Bias in Pasithea Therapeutics Corp.Portfolio Value Report & Consistent Profit Focused Trading Strategies - newsyoung.net
How to integrate Pasithea Therapeutics Corp. into portfolio analysis toolsStop Loss & Daily Stock Trend Reports - Newser
What’s the recovery path for long term holders of Pasithea Therapeutics Corp.July 2025 Closing Moves & Safe Capital Growth Stock Tips - Newser
Historical volatility pattern of Pasithea Therapeutics Corp. Equity Warrant visualizedQuarterly Trade Review & Growth Focused Entry Reports - Newser
Heatmap analysis for Pasithea Therapeutics Corp. Equity Warrant and competitorsTrade Risk Report & Daily Stock Trend Reports - Newser
Leading vs lagging indicators on Pasithea Therapeutics Corp. performance2025 Price Momentum & Risk Controlled Stock Alerts - Newser
Is Pasithea Therapeutics Corp. Equity Warrant stock entering bullish territoryJuly 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Using data models to predict Pasithea Therapeutics Corp. stock movementPortfolio Performance Report & AI Based Trade Execution Alerts - Newser
What institutional flow reveals about Pasithea Therapeutics Corp.Short Setup & Verified Swing Trading Watchlists - Newser
Can Pasithea Therapeutics Corp. Equity Warrant Overcome Bearish SentimentForecast Cut & Short-Term Trading Alerts - Newser
Visual trend scoring systems applied to Pasithea Therapeutics Corp. Equity WarrantEarnings Beat & Safe Swing Trade Setups - Newser
What’s the recovery path for long term holders of Pasithea Therapeutics Corp. Equity Warrant2025 Market Outlook & Intraday High Probability Setup Alerts - Newser
How to escape a deep drawdown in Pasithea Therapeutics Corp. Equity WarrantMarket Activity Report & Safe Entry Momentum Tips - Newser
How to manage a losing position in Pasithea Therapeutics Corp.Jobs Report & Verified Chart Pattern Signals - Newser
Price action breakdown for Pasithea Therapeutics Corp. Equity WarrantGap Down & Free Long-Term Investment Growth Plans - Newser
How moving averages guide Pasithea Therapeutics Corp. Equity Warrant tradingQuarterly Investment Review & Real-Time Buy Zone Alerts - Newser
How to monitor Pasithea Therapeutics Corp. with trend dashboardsMarket Movers & Daily Volume Surge Trade Alerts - Newser
How to read the order book for Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Will Pasithea Therapeutics Corp. Equity Warrant stock go up soonMarket Risk Report & Real-Time Volume Trigger Notifications - Newser
Pasithea Therapeutics Corp.’s Beta Climbs After Market Volatility2025 Market Outlook & Risk Controlled Daily Plans - 선데이타임즈
What data driven models say about Pasithea Therapeutics Corp.’s futureJuly 2025 Drop Watch & Consistent Growth Stock Picks - Newser
Will Pasithea Therapeutics Corp. Equity Warrant stock benefit from interest rate changesCPI Data & Daily Oversold Bounce Ideas - Newser
Published on: 2025-08-19 02:19:11 - Newser
Visualizing Pasithea Therapeutics Corp. Equity Warrant stock with heatmaps2025 Valuation Update & Fast Exit Strategy with Risk Control - Newser
Applying big data sentiment scoring on Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Selloffs & Safe Entry Point Identification - Newser
Using flow based indicators on Pasithea Therapeutics Corp. Equity WarrantDollar Strength & Low Drawdown Momentum Ideas - Newser
Why Pasithea Therapeutics Corp. stock attracts strong analyst attention2025 Winners & Losers & AI Driven Stock Reports - Newser
Using Python tools to backtest Pasithea Therapeutics Corp. strategiesSell Signal & Fast Exit and Entry Strategy Plans - Newser
Published on: 2025-08-18 02:44:16 - Newser
Can trapped investors hope for a rebound in Pasithea Therapeutics Corp.Portfolio Performance Report & Fast Entry High Yield Tips - Newser
Published on: 2025-08-17 06:01:40 - Newser
Pasithea Therapeutics Corp. Equity Warrant Flashes Rebound Signal in Oversold ConditionJuly 2025 News Drivers & Accurate Intraday Trading Signals - metal.it
Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pasithea Therapeutics Corp-Aktie (KTTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
0.88%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):